Oxfenicine

Oxfenicine

SCHEMBL28362139

C=C.NC(C(=O)O)c1ccc(O)cc1.NC(C(=O)O)c1ccc(O)cc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.52
HSD17B10 Q99714 5/20 0.52
ALDH1A1 P00352 5/20 0.52
KMT2A Q03164 5/20 0.52
KDM4E B2RXH2 4/20 0.52
HPGD P15428 4/20 0.52
MEN1 O00255 4/20 0.52
GRM1 Q13255 3/20 0.52
CYP2C9 P11712 3/20 0.52
GRM2 Q14416 2/20 0.52
CYP2C19 P33261 2/20 0.52
GRM8 O00222 2/20 0.50
GRM4 Q14833 2/20 0.50
CYP2D6 P10635 1/20 0.50
GRM6 O15303 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
DRD3 P35462 1/20 0.50
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxfenicine SCHEMBL122315 0.96 HSD17B10 (0.55) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL124861 0.96 HSD17B10 (0.55) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL652186 0.96 HSD17B10 (0.55) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL3492041 0.93 TDP1 (0.53) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL3500341 0.93 TDP1 (0.53) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL3492039 0.93 TDP1 (0.53) TDP1HSD17B10ALDH1A1KMT2AKDM4E
Oxfenicine SCHEMBL29849367 0.88 SRC (0.58) TDP1HSD17B10ALDH1A1KMT2AKDM4E
SCHEMBL13527786 0.86 HSD17B10 (0.61) TDP1HSD17B10ALDH1A1KMT2AKDM4E
SCHEMBL2262988 0.77 HSD17B10 (0.53) TDP1HSD17B10ALDH1A1KMT2AKDM4E
SCHEMBL5329159 0.77 HSD17B10 (0.53) TDP1HSD17B10ALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110869057-A Ultra-small nanoparticles labeled with zirconium-89 and methods thereof 纪念斯隆凯特琳癌症中心 2020-03-06 CN claimed
CN-116648266-A Oligomeric compounds that specifically bind to proteoglycans 菲药物股份有限公司 2023-08-25 CN disclosed
CN-113876962-A Nanoparticle immunoconjugates 纪念斯隆-凯特琳癌症中心 2022-01-04 CN disclosed
CN-107735110-B Nanoparticle immunoconjugates 纪念斯隆-凯特琳癌症中心 2021-11-26 CN disclosed
CN-110869057-A Ultra-small nanoparticles labeled with zirconium-89 and methods thereof 纪念斯隆凯特琳癌症中心 2020-03-06 CN disclosed